Mercer Global Advisors
GMAB icon

Mercer Global Advisors’s Genmab GMAB Stock Holding History

Mercer Global Advisors’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$506K Sell
18,434
-7,627
-29% -$203K ﹤0.01% 2284
2026
Q1 		$699K Sell
26,061
-467
-2% -$14K ﹤0.01% 1763
2025
Q4 		$817K Sell
26,528
-2,001
-7% -$62.4K ﹤0.01% 1568
2025
Q3 		$875K Sell
28,529
-3,938
-12% -$96K ﹤0.01% 1450
2025
Q2 		$671K Sell
32,467
-17,692
-35% -$363K ﹤0.01% 1410
2025
Q1 		$982K Buy
50,159
+29,316
+141% +$615K ﹤0.01% 1158
2024
Q4 		$435K Sell
20,843
-4,804
-19% -$106K ﹤0.01% 1523
2024
Q3 		$619K Sell
25,647
-277
-1% -$7.41K ﹤0.01% 1227
2024
Q2 		$651K Sell
25,924
-3,339
-11% -$94.7K ﹤0.01% 1163
2024
Q1 		$875K Sell
29,263
-16,449
-36% -$483K ﹤0.01% 1026
2023
Q4 		$1.46M Sell
45,712
-9,952
-18% -$312K ﹤0.01% 836
2023
Q3 		$1.96M Buy
55,664
+1,171
+2% +$44.6K 0.01% 709
2023
Q2 		$2.07M Buy
54,493
+3,164
+6% +$126K 0.01% 719
2023
Q1 		$1.94M Sell
51,329
-4,244
-8% -$163K 0.01% 690
2022
Q4 		$2.35M Buy
55,573
+172
+0.3% +$7.09K 0.01% 651
2022
Q3 		$1.78M Buy
55,401
+828
+2% +$29.1K 0.01% 653
2022
Q2 		$1.77M Sell
54,573
-18,021
-25% -$584K 0.01% 644
2022
Q1 		$2.63M Sell
72,594
-28,914
-28% -$992K 0.02% 567
2021
Q4 		$4.02M Sell
101,508
-12,733
-11% -$531K 0.02% 424
2021
Q3 		$4.99M Sell
114,241
-24,062
-17% -$1.08M 0.03% 352
2021
Q2 		$5.65M Sell
138,303
-20,926
-13% -$808K 0.04% 309
2021
Q1 		$5.23M Buy
159,229
+19,323
+14% +$727K 0.05% 291
2020
Q4 		$5.69M Buy
139,906
+50,204
+56% +$1.88M 0.07% 208
2020
Q3 		$3.28M Buy
89,702
+49,111
+121% +$1.78M 0.05% 276
2020
Q2 		$1.38M Buy
40,591
+21,699
+115% +$591K 0.03% 411
2020
Q1 		$400K Buy
+18,892
New +$421K 0.01% 728

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Mercer Global Advisors's GMAB Position: Q2 2026 in Review

Mercer Global Advisors reduced its Genmab (GMAB) stake by 29% in Q2 2026, selling an estimated $203K and leaving 18,434 shares worth $506K. The position accounts for ﹤0.01% of the portfolio, ranked #2284.

Mercer Global Advisors first reported a position in GMAB in Q1 2020 and has held it in 26 quarters since. The position peaked at $5.69M in Q4 2020. 291 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Mercer Global Advisors held 18,434 shares of Genmab worth $506K as of Q2 2026.
  • Mercer Global Advisors sold 7,627 Genmab shares in Q2 2026, an estimated $203K.
  • Genmab made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #2284 holding.
  • Mercer Global Advisors first reported a position in Genmab in Q1 2020 and has held it in 26 quarters since.
  • Mercer Global Advisors's Genmab position peaked at $5.69M in Q4 2020.
  • 291 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.